This inventor holds 2 USPTO granted patents. Top assignee: The Upjohn Co.. Active years: 1984-1995.
Company Filing History:
Years Active: 1984-1995
Title: The Innovations of Tom E Patt
Introduction
Tom E Patt is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of biotechnology, particularly in the development of processes for microbial degradation and antibiotic production. With a total of 2 patents, his work has had a meaningful impact on environmental and medical applications.
Latest Patents
One of Patt's latest patents focuses on the microbial degradation of chemical pollutants. This patent discloses a biologically pure culture of Aureobasidium pullmans, deposited as NRRL 21064. The process involves decreasing the concentration of type A/B chemical pollutants in an aqueous mixture by adding a sufficient amount of a fungal cyclic ether degrading microorganism, along with a cometabolite and oxygen.
Another significant patent pertains to the preparation of lincomycin and clindamycin ribonucleotides. These novel ribonucleotides are highly active against Streptococcus hemolyticus and Staphylococcus aureus in vivo. They are prepared using resting cell or cell-free extracts of Streptomyces rochei, NRRL 3533, or cell-free extracts of Streptomyces coelicolor, NRRL 3532.
Career Highlights
Tom E Patt has been associated with The Upjohn Company, where he has contributed to various innovative projects. His work has been instrumental in advancing the company's research and development efforts in biotechnology.
Collaborations
Throughout his career, Patt has collaborated with notable colleagues, including Alexander D Argoudelis and Vincent P Marshall. These collaborations have further enhanced the scope and impact of his inventions.
Conclusion
Tom E Patt's contributions to biotechnology through his patents demonstrate his commitment to innovation and environmental sustainability. His work continues to influence the fields of microbial degradation and antibiotic development.